Pyxis Oncology, Inc. (PYXS) Social Stream



Pyxis Oncology, Inc. (PYXS): $3.00

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PYXS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

Pyxis Oncology Inc (PYXS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Pyxis Oncology Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 4 $25 $16 $22 $3.59 512.81%
2022-03-29 4 $25 $15 $20 $3.59 457.1%

PYXS reports an average of 202.05% for its upside potential over the past 147 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-02 4 25 16 22.000 13.30 65.41%
2021-11-15 4 25 16 22.000 12.06 82.42%
2021-11-19 4 25 16 22.000 12.92 70.28%
2022-03-22 4 25 15 21.666 4.92 340.37%
2022-03-29 4 25 15 20.000 4.88 309.84%

PYXS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Pyxis Oncology Inc's upside potential (average analyst target price relative to current price) is higher than 289.3% of them.
  • To contextualize these metrics, consider that out of all US stocks, Pyxis Oncology Inc's number of analysts covering the stock is higher than 57.24% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Pyxis Oncology Inc's average analyst price target is greater than 104.88% of them.
  • PYXS has a lower variance in analysts' estimates than -87.18% of stocks in the small market cap category.

Stocks similar to Pyxis Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PVCT, PRVB, and PRTK.

Is PYXS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3541 seconds.